Bioventus03.27.19
Bioventus, a global provider of orthobiologic solutions, is launching OSTEOAMP SELECT Fibers, an innovative addition to its allograft line of OSTEOAMP bone graft substitutes for spine, foot & ankle, orthopaedic, and trauma surgeons. OSTEOAMP SELECT Fibers are uniquely processed to retain essential growth factors supporting bone formation1* and the nanotextured fibers provide a conduit for cell migration.
OSTEOAMP SELECT Fibers also advance the handling properties of allograft bone graft substitutes by providing versatile handling for users. The interlocking fibers have high fluid retention and the ability to expand, while maintaining integrity and position.2 These handling properties allow it to be easily molded and packed into place to conform to irregular bone voids.
“OSTEOAMP SELECT Fibers have already been successfully utilized in multiple procedure types in both spine and foot and ankle specialties. Its absorption profile and ability to expand provide surgeons with clinical flexibility as the interlocking fibers can be easily molded and packed to conform to any bone void,” said Tony Bihl, CEO, Bioventus. “This new allograft solution joins our original OSTEOAMP offerings in putty, sponge and granule formats, giving surgeons more options for bone healing and remodeling while delivering positive patient outcomes.”
OSTEOAMP SELECT Fibers comes in five sizes from 1 to 15 cc and is available now from distributors nationwide. To learn more, visit https://www.BioventusSurgical.com/OSTEOAMPSELECT.
References
1 Tidwell JL., Seaman SA, Vanderploeg EJ, Tom S. In vitro and in vivo characterization of OSTEOAMP allogenic morphogentic proteins. Data on file. Bioventus white paper, 2017.
2 Data on file RPT-000858. OSTEOAMP Absorption Data.
*In vitro performance may not be predictive of performance in humans.
OSTEOAMP SELECT Fibers also advance the handling properties of allograft bone graft substitutes by providing versatile handling for users. The interlocking fibers have high fluid retention and the ability to expand, while maintaining integrity and position.2 These handling properties allow it to be easily molded and packed into place to conform to irregular bone voids.
“OSTEOAMP SELECT Fibers have already been successfully utilized in multiple procedure types in both spine and foot and ankle specialties. Its absorption profile and ability to expand provide surgeons with clinical flexibility as the interlocking fibers can be easily molded and packed to conform to any bone void,” said Tony Bihl, CEO, Bioventus. “This new allograft solution joins our original OSTEOAMP offerings in putty, sponge and granule formats, giving surgeons more options for bone healing and remodeling while delivering positive patient outcomes.”
OSTEOAMP SELECT Fibers comes in five sizes from 1 to 15 cc and is available now from distributors nationwide. To learn more, visit https://www.BioventusSurgical.com/OSTEOAMPSELECT.
References
1 Tidwell JL., Seaman SA, Vanderploeg EJ, Tom S. In vitro and in vivo characterization of OSTEOAMP allogenic morphogentic proteins. Data on file. Bioventus white paper, 2017.
2 Data on file RPT-000858. OSTEOAMP Absorption Data.
*In vitro performance may not be predictive of performance in humans.